Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model
暂无分享,去创建一个
Ian Finlay | Jing Zhao | I. Finlay | D. Morris | T. Junginger | J. Seifert | E. Bolton | Theodor Junginger | Jing Zhao | Joachim K. Seifert | Malcolm P. France | Elaine J. Bolton | David L. Morris | M. France
[1] David L. Morris,et al. World Survey on the Complications of Hepatic and Prostate Cryotherapy , 1999, World Journal of Surgery.
[2] Zeng-chen Ma,et al. Clinical evaluation of cryosurgery in the treatment of primary liver cancer Report of 60 Cases , 1988, Cancer.
[3] David L. Morris,et al. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: Correlates with hepatocellular injury , 1994, World journal of surgery.
[4] Z. Ba,et al. Mechanism of hepatocellular dysfunction during early sepsis. Key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6. , 1997, Archives of Surgery.
[5] J Bastacky,et al. The process of freezing and the mechanism of damage during hepatic cryosurgery. , 1988, Cryobiology.
[6] B. Eisenberg,et al. Cryosurgical ablation of hepatic metastases from colorectal carcinomas. , 1997, The American surgeon.
[7] M. Washington,et al. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers , 1996, Hepatology.
[8] M. L. Weaver,et al. Hepatic cryosurgery in treating colorectal metastases , 1995, Cancer.
[9] M. Miyazaki,et al. Reduced hepatic acute‐phase response after simultaneous resection for gastrointestinal cancer with synchronous liver metastases , 1996, The British journal of surgery.
[10] D. Morris,et al. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. , 1998, Annals of surgery.
[11] R. Strieter,et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.
[12] G. Remuzzi,et al. Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome. , 1989, Nephron.
[13] Boris Rubinsky,et al. Ultrasound‐guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results , 1991, Cancer.
[14] D. Morris,et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. , 1995, Cryobiology.
[15] W. Gill,et al. Repeated Freeze–Thaw Cycles in Cryosurgery , 1968, Nature.
[16] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[17] J. Christman,et al. The role of nuclear factor-kappa B in cytokine gene regulation. , 1997, American journal of respiratory cell and molecular biology.
[18] D. Morris,et al. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer , 1999, The British journal of surgery.
[19] B. Ryffel,et al. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. , 1994, The American journal of pathology.
[20] R. Strieter,et al. Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia / Reperfusion Injury in the Rat , 2022 .
[21] J. Ding,et al. Enhanced Kupffer cell activity after repeated hepatic arterial ischaemia in an experimental model , 1994, The British journal of surgery.
[22] Jing Zhao,et al. Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection , 1998, Journal of surgical oncology.
[23] K. Orita,et al. Changes in IL-6 and IL-8 after hepatectomy in patients with liver cirrhosis. , 1995, Hepato-gastroenterology.
[24] B. Rowlands,et al. Mortality, endotoxaemia and cytokine expression after intermittent and continuous hepatic ischaemia , 1995, The British journal of surgery.
[25] D L Morris,et al. Cryotherapy for liver metastases: A new approach , 1989, The British journal of surgery.
[26] W. Chapman,et al. Acute lung injury after hepatic cryoablation: Correlation with NF-κB activation and cytokine production , 1999 .
[27] M. W. Flye,et al. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. , 1990, Archives of surgery.
[28] H. Bismuth,et al. Place of cryosurgery in the treatment of malignant liver tumors. , 1997, Annals of surgery.
[29] D. Morris,et al. Anaesthetic Experience with Cryotherapy for Treatment of Hepatic Malignancy , 1992, Anaesthesia and intensive care.
[30] D. Morris,et al. A collective review of the world literature on hepatic cryotherapy. , 1998, Journal of the Royal College of Surgeons of Edinburgh.
[31] T. Ravikumar,et al. A 5-year study of cryosurgery in the treatment of liver tumors. , 1991, Archives of surgery.
[32] H. Redl,et al. Kinetics of Endotoxin and Tumor Necrosis Factor Appearance in Portal and Systemic Circulation After Hemorrhagic Shock in Rats , 1995, Annals of surgery.
[33] R. Shapiro,et al. Cryoablation of unresectable malignant liver tumors. , 1996, American journal of surgery.
[34] J. Christman,et al. The Role of Nuclear Factor-k B in Cytokine Gene Regulation , 1998 .
[35] D. Morris,et al. Renal impairment in hepatic cryotherapy. , 1998, Cryobiology.